Targeting human equilibrative nucleoside analog transporter (hENT1) expression through modified low glycemic index diet in pancreatic cancer

Valerio Pazienza, Alessandro Del Nobile Matteo

Research output: Contribution to journalArticlepeer-review

Abstract

Pancreatic cancer is a highly aggressive and chemotherapy-resistant cancer. Up to date, the primary goals of nutrition interventions for pancreatic cancer' patients are to prevent or reverse loss of weight and malnutrition in order to maintain dose and schedule of cancer treatments and/or to manage symptoms due to the lack of enzymes' production by the damaged pancreas. With this script, we sought to underline the potential link between dietary settings and the modulation of chemoresistance in pancreatic cancer.

Original languageEnglish
Pages (from-to)663-664
Number of pages2
JournalBiomedicine and Pharmacotherapy
Volume68
Issue number5
DOIs
Publication statusPublished - 2014

ASJC Scopus subject areas

  • Pharmacology

Fingerprint

Dive into the research topics of 'Targeting human equilibrative nucleoside analog transporter (hENT1) expression through modified low glycemic index diet in pancreatic cancer'. Together they form a unique fingerprint.

Cite this